알츠하이머병 환자에서 해마 위축과 정신병적 증상
Hippocampal Atrophy and Psychotic Symptoms in Patients with Alzheimer’s Disease
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives This study examined the difference in the volume or thickness of the medial temporal lobe between Alzheimer’s disease patients with psychosis (AD+P) and those without psychosis (AD-P). Methods Overall, 31 AD+P patients and 29 AD-P patients were included from the Memory impairment clinics of Pusan National University Hospital in Korea. AD+P was diagnosed according to Jeste and Finkel’s proposed diagnostic criteria for psychosis of Alzheimer’s disease. AD-P included AD patients with no psychotic symptoms during a 5-year follow-up period. Medial temporal volume or thickness was measured by 3-tesla MRI and freesufer analysis. Analysis of variance was used to examine the difference in the volume or thickness of medial temporal lobe between AP+P and AD-P after controlling for age, gender, education years, Clinical Dementia Rating scale-Sum of Box, and total intracranial volume. Results The hippocampal volume in AD+P was smaller than that in AD-P. Conclusion These findings suggest that AD+P is associated with a reduced hippocampal volume.
Abstract
Objectives This study examined the difference in the volume or thickness of the medial temporal lobe between Alzheimer’s disease patients with psychosis (AD+P) and those without psychosis (AD-P). Methods Overall, 31 AD+P patients and 29 AD-P patients were included from the Memory impairment clinics of Pusan National University Hospital in Korea. AD+P was diagnosed according to Jeste and Finkel’s proposed diagnostic criteria for psychosis of Alzheimer’s disease. AD-P included AD patients with no psychotic symptoms during a 5-year follow-up period. Medial temporal volume or thickness was measured by 3-tesla MRI and freesufer analysis. Analysis of variance was used to examine the difference in the volume or thickness of medial temporal lobe between AP+P and AD-P after controlling for age, gender, education years, Clinical Dementia Rating scale-Sum of Box, and total intracranial volume. Results The hippocampal volume in AD+P was smaller than that in AD-P. Conclusion These findings suggest that AD+P is associated with a reduced hippocampal volume.
참고문헌 (24)
- Jeste DV, "Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome", Am J Geriatr Psychiatry, 8, pp.29~34 (2000)
- Schneider LS, "Psychosis of Alzheimer’s disease : clinical characteristics and history", J Psychiatr Res, 38, pp.105~111 (2004)
- Wilson RS, "Hallucinations, cognitive decline, and death in Alzheimer’s disease", Neuroepidemiology, 26, pp.68~75 (2006)
- Scarmeas N, "Delusions and hallucinations are associated with worse outcome in Alzheimer disease", Arch Neurol, 62, pp.1601~1608 (2005)
- Kaufer DI, "Assessing the impact of neuropsychiatric symptoms in Alzheimer’s disease : the Neuropsychiatric Inventory Caregiver Distress Scale", J Am Geriatr Soc, 46, pp.210~215 (1998)
- Palaniyappan L, "The neuroanatomy of psychotic diathesis : a meta-analytic review", J Psychiatr Res, 46, pp.1249~1256 (2012)
- Cummings J, "Psychosis in neurologic disease : neurobiology and pathogenesis", Neuropsychiatry Neuropsychol Behav Neurol, 5, pp.144~150 (1992)
- Zubenko GS, "Neuropathologic and neurochemical correlates of psychosis in primary dementia", Arch Neurol, 48, pp.619~624 (1991)
- Förstl H, "Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease", Br J Psychiatry, 165, pp.53~59 (1994)
- Serra L, "Are the behavioral symptoms of Alzheimer’s disease directly associated with neurodegeneration?", J Alzheimers Dis, 21, pp.627~639 (2010)
- Howanitz E, "Magnetic resonance imaging correlates of psychosis in Alzheimer’s disease", J Nerv Ment Dis, 183, pp.548~549 (1995)
- Jack CR Jr, "Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade", Lancet Neurol, 9, pp.119~128 (2010)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease : report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- Okugawa G, "Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia", Neuropsychobiology, 55, pp.43~46 (2007)
- Fischl B, "Measuring the thickness of the human cerebral cortex from magnetic resonance images", Proc Natl Acad Sci U S A, 97, pp.11050~11055 (2000)
- Staff RT, "Delusions in Alzheimer’s disease : spet evidence of right hemispheric dysfunction", Cortex, 35, pp.549~560 (1999)
- Lopez OL, "The psychotic phenomenon in probable Alzheimer’s disease : a positron emission tomography study", J Neuropsychiatry Clin Neurosci, 13, pp.50~55 (2001)
- Mentis MJ, "Abnormal brain glucose metabolism in the delusional misidentification syndromes : a positron emission tomography study in Alzheimer disease", Biol Psychiatry, 38, pp.438~449 (1995)
- Malloy PF, "The frontal lobes and content-specific delusions", J Neuropsychiatry Clin Neurosci, 6, pp.455~466 (1994)
- Blackwood NJ, "Cognitive neuropsychiatric models of persecutory delusions", Am J Psychiatry, 158, pp.527~539 (2001)
- Emanuel JE, "Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study", Am J Geriatr Psychiatry, 19, pp.160~168 (2011)
- Weamer EA, "The relationship of excess cognitive impairment in MCI and early Alzheimer’s disease to the subsequent emergence of psychosis", Int Psychogeriatr, 21, pp.78~85 (2009)
- Murray PS, "Beta-Amyloid 42", 40 ratio and kalirin expression in Alzheimer disease with psychosis, 2012, pp.33, 2807~2816
- Farber NB, "Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis", Arch Gen Psychiatry, 57, pp.1165~1173 (2000)